Yilmaz Mahshid
Patrimonio netto: 186 696 $ in data 30/06/2026
Patrimonio netto: 186 696 $ in data 30/06/2026
Dr. Yilmaz Mahshid is a Chief Financial Officer at Egetis Therapeutics AB and an Independent Director at InDex Pharmaceuticals AB. He is on the Board of Directors at Medivir AB, InDex Pharmaceuticals AB and Mahshid Advisors AB. Dr. Mahshid was previously employed as an Investment Manager & Controller by Industrifonden, a Research Analyst by Pareto Securities AB, a Research Analyst by Pareto Öhman AB, and a Research Analyst by E.
Öhman J:or Fondkommission AB. He also served on the board at Flerie AB, Avidicare AB and Venaticus Capital AB. He received his doctorate degree from Karolinska Institutet.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/05/2026 | 306.249 ( 0,07% ) | 186 696 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MEDIVIR AB | Direttore/Membro del Consiglio | 05/05/2021 |
| EGETIS THERAPEUTICS AB | Direttore Finanziario/CFO | 01/06/2021 |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore/Membro del Consiglio | 01/04/2020 |
Mahshid Advisors AB | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Venaticus Capital AB | Direttore/Membro del Consiglio | 18/03/2022 |
| EGETIS THERAPEUTICS AB | Direttore Finanziario/CFO | 01/09/2020 |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden invests in companies located in the Nordic region. The firm targets companies operating in the fields of planetary health, life science, deep tech and transformative tech. It provides financing for seed and early stage capital requirements with an investment size of SEK 10 – 50 million. | Comptroller/Controller/Auditor | 30/11/2017 |
Pareto Securities AB
Pareto Securities AB Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/05/2015 |
Pareto Öhman AB
Pareto Öhman AB Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 18/09/2013 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Medivir AB
Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden invests in companies located in the Nordic region. The firm targets companies operating in the fields of planetary health, life science, deep tech and transformative tech. It provides financing for seed and early stage capital requirements with an investment size of SEK 10 – 50 million. | Finance |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
E. Öhman J:or Fondkommission AB
E. Öhman J:or Fondkommission AB Financial ConglomeratesFinance Operates as a capital management company | Finance |
Flerie AB
Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Egetis Therapeutics AB
Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Pareto Öhman AB
Pareto Öhman AB Investment Banks/BrokersFinance Provides brokerage services | Finance |
Pareto Securities AB
Pareto Securities AB Investment Banks/BrokersFinance Provides brokerage services | Finance |
Avidicare AB
Avidicare AB Medical DistributorsDistribution Services Provides products that reduces airborne bacteria and virus pollution at hospitals. | Distribution Services |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Venaticus Capital AB | |
Mahshid Advisors AB |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale